
Global biopharmaceutical company Ipsen has announced a significant investment of €27m to upgrade and expand manufacturing capabilities at its Blanchardstown site in Dublin. Ipsen has invested €52m already this year and has expanded its team in Ireland by more than 20% since 2019. The investment will facilitate increased production of vital medical treatment that helps